Publications

Genome-wide DNA Methylation Signatures Are Determined by DNMT3A/B Sequence Preferences.

Authors: S-Q Mao, SM Cuesta, D Tannahill, S Balasubramanian

E-pub date: 14 Jul 2020

Journal name: Biochemistry

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma.

Authors: AN Lau, Z Li, LV Danai, AM Westermark, AM Darnell, R Ferreira, V Gocheva, S...

E-pub date: 10 Jul 2020

Journal name: Elife

Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma.

Authors: B Tessier-Cloutier, DR Cochrane, AN Karnezis, S Colborne, J Magrill, A Talh...

E-pub date: 1 Jul 2020

Journal name: Hum Pathol

Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome.

Authors: G Friedman, O Levi-Galibov, E David, C Bornstein, A Giladi, M Dadiani, A Ma...

E-pub date: 1 Jul 2020

Journal name: Nat Cancer

Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer

Authors: J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, DG Huntsman, DD Bo...

E-pub date: 1 Jul 2020

Journal name: Clinical Cancer Research

The mutREAD method detects mutational signatures from low quantities of cancer DNA.

Authors: J Perner, S Abbas, K Nowicki-Osuch, G Devonshire, MD Eldridge, S Tavaré, R...

E-pub date: 23 Jun 2020

Journal name: Nat Commun

Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19.

Authors: NK Jones, L Rivett, D Sparkes, S Forrest, S Sridhar, J Young, J Pereira-Dia...

E-pub date: 19 Jun 2020

Journal name: Elife

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

Authors: S Shu, H-J Wu, JY Ge, R Zeid, IS Harris, B Jovanović, K Murphy, B Wang, X ...

E-pub date: 18 Jun 2020

Journal name: Mol Cell

Filters

Research Groups

Core Facilities

Start date

End date

Genome-wide DNA Methylation Signatures Are Determined by DNMT3A/B Sequence Preferences.

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma.

Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma.

Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome.

Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer

The mutREAD method detects mutational signatures from low quantities of cancer DNA.

Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19.

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Genome-wide DNA Methylation Signatures Are Determined by DNMT3A/B Sequence Preferences.

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma.

Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma.

Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome.

Abstract IA12: The Ovarian Tumour Tissue Analysis Consortium: Stratified Prognosis of Ovarian Tumors (OTTA-SPOT) signature for high-grade serous ovarian cancer

The mutREAD method detects mutational signatures from low quantities of cancer DNA.

Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19.

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.